Basit öğe kaydını göster

Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results

dc.contributor.authorZur, Dinah
dc.contributor.authorDegenhardtu, Valentin
dc.contributor.authorUnterlauft, Jan-Darius
dc.contributor.authorCagini, Carlo
dc.contributor.authorMane-Tauty, Valerie
dc.contributor.authorRicci, Giuseppe D'Amico
dc.contributor.authorHindi, Isaac
dc.contributor.authorAgrawal, Kushal
dc.contributor.authorChhablani, Jay
dc.contributor.authorLoewenstein, Anat
dc.contributor.authorRehak, Matus
dc.contributor.authorCebeci, Zafer
dc.contributor.authorBusch, Catharina
dc.contributor.authorFraser-Bell, Samantha
dc.contributor.authorIglicki, Matias
dc.contributor.authorLupidi, Marco
dc.contributor.authorCouturier, Aude
dc.contributor.authorChaikitmongkol, Voraporn
dc.contributor.authorGiancipoli, Ermete
dc.contributor.authorRodriguez-Valdes, Patricio J.
dc.contributor.authorGabrielle, Pierre-Henry
dc.contributor.authorLains, Ines
dc.contributor.authorSantos, Ana Rita
dc.contributor.authorPhornphruet, Atchara Am
dc.date.accessioned2021-03-05T20:59:37Z
dc.date.available2021-03-05T20:59:37Z
dc.date.issued2019
dc.identifier.citationBusch C., Fraser-Bell S., Iglicki M., Lupidi M., Couturier A., Chaikitmongkol V., Giancipoli E., Rodriguez-Valdes P. J. , Gabrielle P., Lains I., et al., "Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results", ACTA DIABETOLOGICA, cilt.56, ss.1341-1350, 2019
dc.identifier.issn0940-5429
dc.identifier.othervv_1032021
dc.identifier.otherav_d6d1507c-467c-4f10-a35c-d56b3b52da65
dc.identifier.urihttp://hdl.handle.net/20.500.12627/141759
dc.identifier.urihttps://doi.org/10.1007/s00592-019-01416-4
dc.description.abstractAimsTo provide 2-year follow-up data on eyes with diabetic macular edema (DME) that were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) injections, comparing functional and anatomical outcomes under continued anti-VEGF therapy versus dexamethasone (DEX) implant.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleReal-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
dc.typeMakale
dc.relation.journalACTA DIABETOLOGICA
dc.contributor.departmentUniversity of Leipzig , ,
dc.identifier.volume56
dc.identifier.issue12
dc.identifier.startpage1341
dc.identifier.endpage1350
dc.contributor.firstauthorID272074


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster